45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
22,285
Insurances with rates
5
CPT / HCPCS codes
19,657
Most expensive procedures (gross)
33249
$67,899
INSJ/RPLCMT PERM DFB W/TRNSVNS LDS 1/DUAL CHMBR
Gross
$96,999
J2350
$62,928
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION
Gross
$89,897
J9042
$57,251
BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION
Gross
$81,787
33262
$45,842
RMVL IMPLTBL DFB PLSE GEN W/REPL PLSE GEN 1 LEAD
Gross
$65,488
33274
$40,215
TCAT INSJ/RPL PERM LEADLESS PACEMAKER RV W/IMG
Gross
$57,450
33207
$26,396
INS NEW/RPLC PRM PACEMAKER W/TRANSV ELTRD VENTR
Gross
$37,708
J9334
$23,778
EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN
Gross
$33,969
J9026
$22,387
TARLATAMAB-DLLE 10 MG INTRAVENOUS SOLUTION
Gross
$31,982
33208
$22,039
INS NEW/RPLCMT PRM PM W/TRANSV ELTRD ATRIAL&VENT
Gross
$31,484
33228
$20,767
REMVL PERM PM PLS GEN W/REPL PLSE GEN 2 LEAD SYS
Gross
$29,667
J9173
$18,669
DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION
Gross
$26,670
J9228
$17,933
IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$25,618
J1302
$17,453
SUTIMLIMAB-JOME 50 MG/ML INTRAVENOUS SOLUTION
Gross
$24,933
J9271
$17,433
PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION
Gross
$24,905
33285
$16,321
INSERTION SUBQ CARDIAC RHYTHM MONITOR W/PRGRMG
Gross
$23,315
J2327
$15,791
RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION
Gross
$22,559
J9144
$15,319
DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN
Gross
$21,884
J3380
$14,648
VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION
Gross
$20,925
J1930
$14,409
LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$20,584
J9301
$13,694
OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION
Gross
$19,562
J9177
$13,228
ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION
Gross
$18,898
J2323
$12,866
NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION
Gross
$18,380
J9380
$12,744
TECLISTAMAB-CQYV 90 MG/ML SUBCUTANEOUS SOLUTION
Gross
$18,205
C1764
$12,621
C1764 LOOP RECORDER TIER 2
Gross
$18,030
J3101
$12,383
TENECTEPLASE 50 MG INTRAVENOUS SOLUTION
Gross
$17,691
J9022
$12,108
ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION
Gross
$17,297
J9223
$11,881
LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION
Gross
$16,974
J9299
$11,740
NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION
Gross
$16,771
J1561
$11,099
IMMUNE GLOB G 10%-GLY-IGA AVE 46 MCG/ML INJECTION SOLUTION - MIXTURE COMPONENT WRAPPER
Gross
$15,856
J2353
$10,016
OCTREOTIDE,MICROSPHERES ER 30 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE
Gross
$14,309
J9055
$9,842
CETUXIMAB 100 MG/50 ML INTRAVENOUS SOLUTION
Gross
$14,060
J9311
$9,529
RITUXIMAB 1,400 MG/11.7 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN
Gross
$13,614
J1306
$9,403
INCLISIRAN 284 MG/1.5 ML SUBCUTANEOUS SYRINGE
Gross
$13,434
93451
$9,185
RIGHT HEART CATH O2 SATURATION & CARDIAC OUTPUT
Gross
$13,121
93453
$9,185
R & L HRT CATH W/NJX L VENTRICULOG IMG S&I
Gross
$13,121
93458
$9,185
CATH PLMT L HRT & ARTS W/NJX & ANGIO IMG S&I
Gross
$13,121
93459
$9,185
CATH PLMT L HRT/ARTS/GRFTS WNJX & ANGIO IMG S&I
Gross
$13,121
J9036
$8,748
BENDAMUSTINE 25 MG/ML INTRAVENOUS SOLUTION
Gross
$12,497
J0517
$8,727
BENRALIZUMAB 30 MG/ML SUBCUTANEOUS SYRINGE
Gross
$12,467
J0717
$8,693
CERTOLIZUMAB PEGOL 400 MG/2 ML (200 MG/ML X2) SUBCUTANEOUS SYRINGE KIT
Gross
$12,419
J1602
$8,691
GOLIMUMAB 12.5 MG/ML INTRAVENOUS SOLUTION
Gross
$12,415
J9303
$8,269
PANITUMUMAB 100 MG/5 ML (20 MG/ML) INTRAVENOUS SOLUTION
Gross
$11,813
Q5103
$8,227
INFLIXIMAB-DYYB 100 MG INTRAVENOUS SOLUTION
Gross
$11,753
J9034
$7,886
BENDAMUSTINE 25 MG/ML INTRAVENOUS SOLUTION
Gross
$11,266
J0256
$7,858
ALPHA-1-PROTEINASE INHIBITOR (HUMAN) 5,000 MG INTRAVENOUS SOLUTION
Gross
$11,226
J9354
$7,756
ADO-TRASTUZUMAB EMTANSINE 160 MG INTRAVENOUS SOLUTION
Gross
$11,080
J0875
$7,733
DALBAVANCIN 500 MG INTRAVENOUS SOLUTION
Gross
$11,048
Q5104
$7,642
INFLIXIMAB-ABDA 100 MG INTRAVENOUS SOLUTION
Gross
$10,917
J1569
$7,590
IMMUNE GLOB,GAMMA (IGG) 10 %-GLY-IGA OVER 50 MCG/ML INJECTION SOLUTION
Gross
$10,843
J0177
$7,089
AFLIBERCEPT 8 MG/0.07 ML INTRAVITREAL SOLUTION FOR INJECTION
Gross
$10,128
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 33249 | INSJ/RPLCMT PERM DFB W/TRNSVNS LDS 1/DUAL CHMBR | $96,999 | $67,899 | — | — | 17 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $89,897 | $62,928 | — | — | 18 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $81,787 | $57,251 | — | — | 6 |
| 33262 | RMVL IMPLTBL DFB PLSE GEN W/REPL PLSE GEN 1 LEAD | $65,488 | $45,842 | — | — | 5 |
| 33274 | TCAT INSJ/RPL PERM LEADLESS PACEMAKER RV W/IMG | $57,450 | $40,215 | — | — | 23 |
| 33207 | INS NEW/RPLC PRM PACEMAKER W/TRANSV ELTRD VENTR | $37,708 | $26,396 | — | — | 5 |
| J9334 | EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN | $33,969 | $23,778 | — | — | 6 |
| J9026 | TARLATAMAB-DLLE 10 MG INTRAVENOUS SOLUTION | $31,982 | $22,387 | — | — | 12 |
| 33208 | INS NEW/RPLCMT PRM PM W/TRANSV ELTRD ATRIAL&VENT | $31,484 | $22,039 | — | — | 17 |
| 33228 | REMVL PERM PM PLS GEN W/REPL PLSE GEN 2 LEAD SYS | $29,667 | $20,767 | — | — | 17 |
| J9173 | DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION | $26,670 | $18,669 | — | — | 12 |
| J9228 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION | $25,618 | $17,933 | — | — | 18 |
| J1302 | SUTIMLIMAB-JOME 50 MG/ML INTRAVENOUS SOLUTION | $24,933 | $17,453 | — | — | 12 |
| J9271 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION | $24,905 | $17,433 | — | — | 18 |
| 33285 | INSERTION SUBQ CARDIAC RHYTHM MONITOR W/PRGRMG | $23,315 | $16,321 | — | — | 17 |
| J2327 | RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION | $22,559 | $15,791 | — | — | 6 |
| J9144 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $21,884 | $15,319 | — | — | 12 |
| J3380 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION | $20,925 | $14,648 | — | — | 6 |
| J1930 | LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE | $20,584 | $14,409 | — | — | 6 |
| J9301 | OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION | $19,562 | $13,694 | — | — | 12 |
| J9177 | ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION | $18,898 | $13,228 | — | — | 30 |
| J2323 | NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION | $18,380 | $12,866 | — | — | 6 |
| J9380 | TECLISTAMAB-CQYV 90 MG/ML SUBCUTANEOUS SOLUTION | $18,205 | $12,744 | — | — | 30 |
| C1764 | C1764 LOOP RECORDER TIER 2 | $18,030 | $12,621 | — | — | 6 |
| J3101 | TENECTEPLASE 50 MG INTRAVENOUS SOLUTION | $17,691 | $12,383 | — | — | 6 |
| J9022 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION | $17,297 | $12,108 | — | — | 12 |
| J9223 | LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION | $16,974 | $11,881 | — | — | 24 |
| J9299 | NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION | $16,771 | $11,740 | — | — | 12 |
| J1561 | IMMUNE GLOB G 10%-GLY-IGA AVE 46 MCG/ML INJECTION SOLUTION - MIXTURE COMPONENT WRAPPER | $15,856 | $11,099 | — | — | 60 |
| J2353 | OCTREOTIDE,MICROSPHERES ER 30 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE | $14,309 | $10,016 | — | — | 6 |
| J9055 | CETUXIMAB 100 MG/50 ML INTRAVENOUS SOLUTION | $14,060 | $9,842 | — | — | 48 |
| J9311 | RITUXIMAB 1,400 MG/11.7 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN | $13,614 | $9,529 | — | — | 6 |
| J1306 | INCLISIRAN 284 MG/1.5 ML SUBCUTANEOUS SYRINGE | $13,434 | $9,403 | — | — | 6 |
| 93451 | RIGHT HEART CATH O2 SATURATION & CARDIAC OUTPUT | $13,121 | $9,185 | — | — | 10 |
| 93453 | R & L HRT CATH W/NJX L VENTRICULOG IMG S&I | $13,121 | $9,185 | — | — | 5 |
| 93458 | CATH PLMT L HRT & ARTS W/NJX & ANGIO IMG S&I | $13,121 | $9,185 | — | — | 15 |
| 93459 | CATH PLMT L HRT/ARTS/GRFTS WNJX & ANGIO IMG S&I | $13,121 | $9,185 | — | — | 10 |
| J9036 | BENDAMUSTINE 25 MG/ML INTRAVENOUS SOLUTION | $12,497 | $8,748 | — | — | 6 |
| J0517 | BENRALIZUMAB 30 MG/ML SUBCUTANEOUS SYRINGE | $12,467 | $8,727 | — | — | 6 |
| J0717 | CERTOLIZUMAB PEGOL 400 MG/2 ML (200 MG/ML X2) SUBCUTANEOUS SYRINGE KIT | $12,419 | $8,693 | — | — | 12 |
| J1602 | GOLIMUMAB 12.5 MG/ML INTRAVENOUS SOLUTION | $12,415 | $8,691 | — | — | 6 |
| J9303 | PANITUMUMAB 100 MG/5 ML (20 MG/ML) INTRAVENOUS SOLUTION | $11,813 | $8,269 | — | — | 12 |
| Q5103 | INFLIXIMAB-DYYB 100 MG INTRAVENOUS SOLUTION | $11,753 | $8,227 | — | — | 24 |
| J9034 | BENDAMUSTINE 25 MG/ML INTRAVENOUS SOLUTION | $11,266 | $7,886 | — | — | 6 |
| J0256 | ALPHA-1-PROTEINASE INHIBITOR (HUMAN) 5,000 MG INTRAVENOUS SOLUTION | $11,226 | $7,858 | — | — | 6 |
| J9354 | ADO-TRASTUZUMAB EMTANSINE 160 MG INTRAVENOUS SOLUTION | $11,080 | $7,756 | — | — | 12 |
| J0875 | DALBAVANCIN 500 MG INTRAVENOUS SOLUTION | $11,048 | $7,733 | — | — | 12 |
| Q5104 | INFLIXIMAB-ABDA 100 MG INTRAVENOUS SOLUTION | $10,917 | $7,642 | — | — | 30 |
| J1569 | IMMUNE GLOB,GAMMA (IGG) 10 %-GLY-IGA OVER 50 MCG/ML INJECTION SOLUTION | $10,843 | $7,590 | — | — | 12 |
| J0177 | AFLIBERCEPT 8 MG/0.07 ML INTRAVITREAL SOLUTION FOR INJECTION | $10,128 | $7,089 | — | — | 6 |
Showing top 50 of 22,285 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.